共 29 条
[2]
[5]
Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels.[J].Matti J. Tikkanen;Rana Fayyad;Ole Faergeman;Anders G. Olsson;Chuan-Chuan Wun;Rachel Laskey;John J. Kastelein;Ingar Holme;Terje R. Pedersen.International Journal of Cardiology.2013,
[7]
Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property.[J].Hideyuki Hyogo;Sho-ichi Yamagishi;Sayaka Maeda;Yuki Kimura;Tomokazu Ishitobi;Kazuaki Chayama.Digestive and Liver Disease.2011, 6
[9]
The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases; American College of Gastroenterology; and the American Gastroenterological Association.[J].Naga Chalasani;Zobair Younossi;Joel E. Lavine;Anna Mae Diehl;Elizabeth M. Brunt;Kenneth Cusi;Michael Charlton;Arun J. Sanyal.Hepatology.2012, 6

